{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:09:31Z","timestamp":1784837371655,"version":"3.55.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:title>AbstractAbstract<\/jats:title>\n                  <jats:p>\n                    Antioxidant pretreatment with\n                    <jats:italic toggle=\"yes\">N<\/jats:italic>\n                    -acetylcysteine and Trolox protected calsequestrin-1-null mice from otherwise lethal episodes triggered by exposure to either halothane or heat stress. The results support evidence for a potential role of oxidative stress in life-threatening events of malignant hyperthermia and heat stress.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Mice lacking calsequestrin-1 (CASQ1-null), a Ca\n                      <jats:sup>2+<\/jats:sup>\n                      -binding protein that modulates the activity of Ca\n                      <jats:sup>2+<\/jats:sup>\n                      release in the skeletal muscle, exhibit lethal hypermetabolic episodes that resemble malignant hyperthermia in humans when exposed to halothane or heat stress.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Because oxidative species may play a critical role in malignant hyperthermia crises, we treated CASQ1-null mice with two antioxidants,\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -acetylcysteine (NAC, Sigma-Aldrich, Italy; provided\n                      <jats:italic toggle=\"yes\">ad libitum<\/jats:italic>\n                      in drinking water) and (\u00b1)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox, Sigma-Aldrich; administered by intraperitoneal injection), before exposure to halothane (2%, 1 h) or heat (41\u00b0C, 1 h).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      NAC and Trolox significantly protected CASQ1-null mice from lethal episodes, with mortality being 79% (n = 14), 25% (n = 16), and 20% (n = 5) during halothane exposure and 86% (n = 21), 29% (n = 21), and 33% (n = 6) during heat stress in untreated, NAC-treated, and Trolox-treated mice, respectively. During heat challenge, an increase in core temperature in CASQ1-null mice (42.3\u00b0 \u00b1 0.1\u00b0C, n=10) was significantly reduced by both NAC and Trolox (40.6\u00b0 \u00b1 0.3\u00b0C, n = 6 and 40.5\u00b0 \u00b1 0.2\u00b0C, n = 6). NAC treatment of CASQ1-null muscles\/mice normalized caffeine sensitivity during\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      contracture tests, Ca\n                      <jats:sup>2+<\/jats:sup>\n                      transients in single fibers, and significantly reduced the percentage of fibers undergoing rhabdomyolysis (37.6 \u00b1 2.5%, 38\/101 fibers in 3 mice; 11.6 \u00b1 1.1%, 21\/186 fibers in 5 mice). The protective effect of antioxidant treatment likely resulted from mitigation of oxidative stress, because NAC reduced mitochondrial superoxide production, superoxide dismutase type-1 expression, and 3-nitrotyrosine expression, and increased both reduced glutathione and reduced glutathione\/oxidized glutathione ratio.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These studies provide a deeper understanding of the mechanisms that underlie hyperthermic crises in CASQ1-deficient muscle and demonstrate that antioxidant pretreatment may prevent them.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aln.0000000000000748","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T09:55:47Z","timestamp":1435744547000},"page":"603-617","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":36,"title":["Antioxidants Protect Calsequestrin-1 Knockout Mice from Halothane- and Heat-induced Sudden Death"],"prefix":"10.1097","volume":"123","author":[{"given":"Antonio","family":"Michelucci","sequence":"first","affiliation":[{"name":"From the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d\u2032Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Paolini","sequence":"additional","affiliation":[{"name":"From the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d\u2032Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Canato","sequence":"additional","affiliation":[{"name":"From the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d\u2032Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wei-Lapierre","sequence":"additional","affiliation":[{"name":"From the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d\u2032Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pietrangelo","sequence":"additional","affiliation":[{"name":"From the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d\u2032Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"De Marco","sequence":"additional","affiliation":[{"name":"From the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d\u2032Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Reggiani","sequence":"additional","affiliation":[{"name":"From the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d\u2032Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Dirksen","sequence":"additional","affiliation":[{"name":"From the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d\u2032Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciano","family":"Protasi","sequence":"additional","affiliation":[{"name":"From the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d\u2032Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20241223","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1152\/physrev.1997.77.3.699","article-title":"Ryanodine receptors of striated muscles: A complex channel capable of multiple interactions.","volume":"77","year":"1997","journal-title":"Physiol Rev"},{"key":"R2-20241223","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(98)03078-5","article-title":"Malignant hyperthermia.","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"R3-20241223","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.256.5058.789","article-title":"Malignant hyperthermia.","volume":"256","year":"1992","journal-title":"Science"},{"key":"R4-20241223","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00131402-200212000-00004","article-title":"Current concepts in malignant hyperthermia.","volume":"4","year":"2002","journal-title":"J Clin Neuromuscul Dis"},{"key":"R5-20241223","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/bja\/aeq243","article-title":"Recognizing and managing a malignant hyperthermia crisis: Guidelines from the European Malignant Hyperthermia Group.","volume":"105","year":"2010","journal-title":"Br J Anaesth"},{"key":"R6-20241223","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.","volume":"56","year":"1984","journal-title":"Br J Anaesth"},{"key":"R7-20241223","first-page":"511","article-title":"Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.","volume":"69","year":"1989","journal-title":"Anesth Analg"},{"key":"R8-20241223","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/ALN.0b013e318232008f","article-title":"Nonanesthetic malignant hyperthermia.","volume":"115","year":"2011","journal-title":"Anesthesiology"},{"key":"R9-20241223","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra011089","article-title":"Heat stroke.","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"R10-20241223","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/0140-6736(91)92304-K","article-title":"Evidence for related myopathies in exertional heat stroke and malignant hyperthermia.","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"R11-20241223","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bja\/88.4.508","article-title":"Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees.","volume":"88","year":"2002","journal-title":"Br J Anaesth"},{"key":"R12-20241223","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/ALN.0b013e3181c29504","article-title":"Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms.","volume":"112","year":"2010","journal-title":"Anesthesiology"},{"key":"R13-20241223","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/ALN.0b013e3182320068","article-title":"Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families.","volume":"115","year":"2011","journal-title":"Anesthesiology"},{"key":"R14-20241223","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.286.2.168","article-title":"Malignant hyperthermia and apparent heat stroke.","volume":"286","year":"2001","journal-title":"JAMA"},{"key":"R15-20241223","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00000542-197201000-00009","article-title":"Malignant hyperthermia of Poland China swine: Studies of a myogenic etiology.","volume":"36","year":"1972","journal-title":"Anesthesiology"},{"key":"R16-20241223","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000542-197201000-00008","article-title":"Malignant hyperthermia of swine.","volume":"36","year":"1972","journal-title":"Anesthesiology"},{"key":"R17-20241223","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.05-4497fje","article-title":"Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.","volume":"20","year":"2006","journal-title":"FASEB J"},{"key":"R18-20241223","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00000542-200612000-00016","article-title":"Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.","volume":"105","year":"2006","journal-title":"Anesthesiology"},{"key":"R19-20241223","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1096\/fj.08-121335","article-title":"Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice.","volume":"23","year":"2009","journal-title":"FASEB J"},{"issue":"pt 13","key":"R20-20241223","first-page":"3095","article-title":"Calsequestrin-1: A new candidate gene for malignant hyperthermia and exertional\/environmental heat stroke.","volume":"587","year":"2009","journal-title":"J Physiol"},{"issue":"pt 2","key":"R21-20241223","first-page":"767","article-title":"Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin-1.","volume":"583","year":"2007","journal-title":"J Physiol"},{"key":"R22-20241223","doi-asserted-by":"crossref","first-page":"22326","DOI":"10.1073\/pnas.1009168108","article-title":"Massive alterations of sarcoplasmic reticulum free calcium in skeletal muscle fibers lacking calsequestrin revealed by a genetically encoded probe.","volume":"107","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R23-20241223","first-page":"634075","article-title":"Differential effect of calsequestrin ablation on structure and function of fast and slow skeletal muscle fibers.","volume":"2011","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"R24-20241223","doi-asserted-by":"crossref","first-page":"e77633","DOI":"10.1371\/journal.pone.0077633","article-title":"Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death.","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"R25-20241223","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.anes.0000530185.78660.da","article-title":"CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population.","volume":"118","year":"2013","journal-title":"Anesthesiology"},{"key":"R26-20241223","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cell.2008.02.042","article-title":"RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice.","volume":"133","year":"2008","journal-title":"Cell"},{"key":"R27-20241223","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1113\/expphysiol.2009.050245","article-title":"Is oxidative stress a cause or consequence of disuse muscle atrophy in mice? A proteomic approach in hindlimb-unloaded mice.","volume":"95","year":"2010","journal-title":"Exp Physiol"},{"key":"R28-20241223","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0960-8966(01)00232-2","article-title":"Three mouse models of muscular dystrophy: The natural history of strength and fatigue in dystrophin-, dystrophin\/utrophin-, and laminin alpha2-deficient mice.","volume":"11","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"R29-20241223","doi-asserted-by":"crossref","first-page":"21996","DOI":"10.1073\/pnas.0911496106","article-title":"Characterization and temporal development of cores in a mouse model of malignant hyperthermia.","volume":"106","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R30-20241223","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jemt.20177","article-title":"Imaging and elasticity measurements of the sarcolemma of fully differentiated skeletal muscle fibres.","volume":"67","year":"2005","journal-title":"Microsc Res Tech"},{"key":"R31-20241223","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1096\/fj.11-187252","article-title":"Mitochondrial superoxide flashes: Metabolic biomarkers of skeletal muscle activity and disease.","volume":"25","year":"2011","journal-title":"FASEB J"},{"key":"R32-20241223","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1038\/nprot.2006.378","article-title":"Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method.","volume":"1","year":"2006","journal-title":"Nat Protoc"},{"key":"R33-20241223","first-page":"6049","article-title":"Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).","volume":"244","year":"1969","journal-title":"J Biol Chem"},{"key":"R34-20241223","first-page":"181","article-title":"Biomarkers of oxidative\/nitrosative stress: An approach to disease prevention.","volume":"61","year":"2007","journal-title":"Acta Med Okayama"},{"key":"R35-20241223","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0076-6879(99)99026-2","article-title":"Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage.","volume":"299","year":"1999","journal-title":"Methods Enzymol"},{"key":"R36-20241223","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(98)00258-5","article-title":"Evidence of oxidative stress in mdx mouse muscle: Studies of the pre-necrotic state.","volume":"161","year":"1998","journal-title":"J Neurol Sci"},{"key":"R37-20241223","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0891-5849(03)00186-2","article-title":"Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle.","volume":"35","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"R38-20241223","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/mus.20542","article-title":"Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle.","volume":"33","year":"2006","journal-title":"Muscle Nerve"},{"key":"R39-20241223","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/10715761003692487","article-title":"Oxidative stress in the denervated muscle.","volume":"44","year":"2010","journal-title":"Free Radic Res"},{"key":"R40-20241223","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10974-011-9277-2","article-title":"Lessons from calsequestrin-1 ablation in vivo: Much more than a Ca(2+) buffer after all.","volume":"32","year":"2011","journal-title":"J Muscle Res Cell Motil"},{"key":"R41-20241223","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","article-title":"Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.","volume":"27","year":"2006","journal-title":"Hum Mutat"},{"key":"R42-20241223","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease.","volume":"27","year":"2006","journal-title":"Hum Mutat"},{"key":"R43-20241223","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","article-title":"Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.","volume":"60","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R44-20241223","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2350-10-104","article-title":"The role of CACNA1S in predisposition to malignant hyperthermia.","volume":"10","year":"2009","journal-title":"BMC Med Genet"},{"key":"R45-20241223","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/humu.22631","article-title":"A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates.","volume":"35","year":"2014","journal-title":"Hum Mutat"},{"key":"R46-20241223","first-page":"301","article-title":"Porcine malignant hyperthermia: Effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.","volume":"42","year":"1975","journal-title":"Anesthesiology"},{"key":"R47-20241223","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/BF03006495","article-title":"The importance of calcium ions for in vitro malignant hyperthermia testing.","volume":"37","year":"1990","journal-title":"Can J Anaesth"},{"key":"R48-20241223","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000542-199109000-00006","article-title":"Effects of calcium-free solution, calcium antagonists, and the calcium agonist BAY K 8644 on mechanical responses of skeletal muscle from patients susceptible to malignant hyperthermia.","volume":"75","year":"1991","journal-title":"Anesthesiology"},{"issue":"pt 20","key":"R49-20241223","first-page":"4815","article-title":"Differential dependence of store-operated and excitation-coupled Ca2+ entry in skeletal muscle on STIM1 and Orai1.","volume":"586","year":"2008","journal-title":"J Physiol"},{"key":"R50-20241223","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/ncomms3805","article-title":"Orai1-dependent calcium entry promotes skeletal muscle growth and limits fatigue.","volume":"4","year":"2013","journal-title":"Nat Commun"},{"key":"R51-20241223","doi-asserted-by":"crossref","first-page":"25645","DOI":"10.1074\/jbc.M110.104976","article-title":"Store-operated Ca2+ entry in malignant hyperthermia-susceptible human skeletal muscle.","volume":"285","year":"2010","journal-title":"J Biol Chem"},{"issue":"1 pt 1","key":"R52-20241223","first-page":"310","article-title":"Calsequestrin is an inhibitor of skeletal muscle ryanodine receptor calcium release channels.","volume":"82","year":"2002","journal-title":"Biophys J"},{"key":"R53-20241223","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1085\/jgp.201010454","article-title":"Paradoxical buffering of calcium by calsequestrin demonstrated for the calcium store of skeletal muscle.","volume":"136","year":"2010","journal-title":"J Gen Physiol"},{"key":"R54-20241223","doi-asserted-by":"crossref","first-page":"C575","DOI":"10.1152\/ajpcell.00119.2011","article-title":"Calsequestrin (CASQ1) rescues function and structure of calcium release units in skeletal muscles of CASQ1-null mice.","volume":"302","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"R55-20241223","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0092-8674(00)00054-4","article-title":"The skeletal muscle calcium release channel: Coupled O2 sensor and NO signaling functions.","volume":"102","year":"2000","journal-title":"Cell"},{"key":"R56-20241223","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1073\/pnas.201289098","article-title":"Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO.","volume":"98","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R57-20241223","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.1074\/jbc.M211940200","article-title":"Nitric oxide, NOC-12, and S-nitrosoglutathione modulate the skeletal muscle calcium release channel\/ryanodine receptor by different mechanisms. An allosteric function for O2 in S-nitrosylation of the channel.","volume":"278","year":"2003","journal-title":"J Biol Chem"},{"key":"R58-20241223","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nm.1916","article-title":"Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle.","volume":"15","year":"2009","journal-title":"Nat Med"},{"key":"R59-20241223","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2008.06.051","article-title":"AMPK and PPARdelta agonists are exercise mimetics.","volume":"134","year":"2008","journal-title":"Cell"},{"key":"R60-20241223","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nm.2598","article-title":"AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation.","volume":"18","year":"2012","journal-title":"Nat Med"},{"key":"R61-20241223","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4065\/70.3.241","article-title":"Clinical effects of intravenously administered dantrolene.","volume":"70","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"R62-20241223","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1085\/jgp.118.4.355","article-title":"Effects of dantrolene on steps of excitation-contraction coupling in mammalian skeletal muscle fibers.","volume":"118","year":"2001","journal-title":"J Gen Physiol"},{"key":"R63-20241223","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1124\/mol.107.043299","article-title":"Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene.","volume":"73","year":"2008","journal-title":"Mol Pharmacol"},{"key":"R64-20241223","doi-asserted-by":"crossref","first-page":"33477","DOI":"10.1074\/jbc.M602306200","article-title":"Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor.","volume":"281","year":"2006","journal-title":"J Biol Chem"},{"key":"R65-20241223","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/mus.20385","article-title":"Effects of N-acetylcysteine on glutathione oxidation and fatigue during handgrip exercise.","volume":"32","year":"2005","journal-title":"Muscle Nerve"}],"container-title":["Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.asahq.org\/anesthesiology\/article-pdf\/123\/3\/603\/485969\/20150900_0-00023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/anesthesiology.pubs.asahq.org\/article.aspx?volume=123&page=603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:33:42Z","timestamp":1784835222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/ALN.0000000000000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/aln.0000000000000748","relation":{},"ISSN":["0003-3022"],"issn-type":[{"value":"0003-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}